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ABSTRACT: Combinatorial post-translational modiﬁcations
(PTMs), which can serve as dynamic “molecular barcodes”, have
been proposed to regulate distinct protein functions. However,
studies of combinatorial PTMs on single protein molecules have
been hindered by a lack of suitable analytical methods. Here, we
describe erasable single-molecule blotting (eSiMBlot) for
combinatorial PTM proﬁling. This assay is performed in a highly
multiplexed manner and leverages the beneﬁts of covalent protein
immobilization, cyclic probing with diﬀerent antibodies, and single
molecule ﬂuorescence imaging. Especially, facile and eﬃcient covalent immobilization on a surface using Cu-free click chemistry
permits multiple rounds (>10) of antibody erasing/reprobing without loss of antigenicity. Moreover, cumulative detection of
coregistered multiple data sets for immobilized single-epitope molecules, such as HA peptide, can be used to increase the
antibody detection rate. Finally, eSiMBlot enables direct visualization and quantitative proﬁling of combinatorial PTM codes at
the single-molecule level, as we demonstrate by revealing the novel phospho-codes of ligand-induced epidermal growth factor
receptor. Thus, eSiMBlot provides an unprecedentedly simple, rapid, and versatile platform for analyzing the vast number of
combinatorial PTMs in biological pathways.
■ INTRODUCTION
Determining how proteins are regulated to generate diverse
protein functions is an important topic of research in the
postgenomic era. Protein function is coordinated by various
multilayered and interconnected mechanisms, including tran-
scription of new mRNA, alternative RNA splicing, and
translation of the mature mRNA into protein.1 Among these
diverse regulatory mechanisms, post-translational modiﬁcations
(PTMs) provide enormous potential for indexing and
exponential expansion of the protein repertoire,2 and also
have the advantages of being highly dynamic and largely
reversible.1 Accumulating evidence suggests that PTMs ﬁne-
tune protein functions to provide rapid responses to stimuli
without requiring genomic, transcriptomic, or translational
regulation.3 Multiple sites of individual proteins can be
subjected to a wide range of covalent modiﬁcations to
orchestrate an integrated response to environmental signals.
Thus, combinatorial PTMs (“PTM codes”) such as the histone
code can exert distinct biological eﬀects and exponentially
expand the diversity of possible proteoforms.4,5 Currently,
conventional methods such as western blotting6 and mass
spectrometry7,8 are widely used as “gold standards” for PTM
studies. However, information regarding combinatorial PTM
codes can be concealed by conventional ensemble-averaging
measurements, especially when diﬀerent sites on the same
protein are simultaneously modiﬁed.5 Consequently, PTM
codes contain a wealth of functional information that we are
currently unable to access. There are several inherent
limitations with the previously reported single-molecule PTM
proﬁling techniques, which detract from their utility.9−12
Among these, the most critical is a low multiplexing capability
which is limited to only di-post-translationally modiﬁed
proteins.
Here, we developed an erasable single-molecule blot
(eSiMBlot) assay using a Cu-free click reaction, which allows
a single protein to be assayed, and reassayed, multiple times
using several diﬀerent antibodies to reveal PTM codes. This
new assay consists of three parts. The ﬁrst is the stable and
robust immobilization of the protein onto a surface using a Cu-
free click reaction; the second part is cyclic probing13,14 of the
surface various antibodies; the third part is imaging of the
bound antibodies with a single-molecule level ﬂuorescence
imaging. Since the proteins are stably anchored on the surface
by the Cu-free click reaction, the surface can be subjected to
multiple cycles of imaging and erasing, using site-speciﬁc anti-
PTM antibodies in conjunction with single-molecule ﬂuo-
rescence microscopy. The eSiMBlot provides a simple, rapid,
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and direct method for unravelling the PTM codes of a single
protein.
■ RESULTS
Scheme of eSiMBlot. As schematically illustrated in Figure
1a, the eSiMBlot technology consists of three main steps. First,
as in the SiMBlot assay, the protein of interest is securely
immobilized on the imaging surface (hereafter, termed the
single-molecule surface) and probed with a primary antibody
speciﬁc for a modiﬁed site of interest (i.e., a site-speciﬁc
modiﬁcation antibody), followed by a ﬂuorescently labeled
secondary antibody (Figure 1a, left). In the second step, total
internal reﬂection ﬂuorescence microscopy is used to acquire
ﬂuorescence images in separate channels, yielding localization
information for the ﬁducial marker and site-speciﬁcally
modiﬁed proteins probed by immunoﬂuorescence (IF) with a
site-speciﬁc modiﬁcation antibody (Figure 1a, middle). In the
third step, without any disturbance of the immobilized antigen
proteins, IF antibodies are speciﬁcally cleared from the single-
molecule surface using the erasing buﬀer, and the immobilized
proteins are reinitialized for the next round of IF with a
diﬀerent site-speciﬁc modiﬁcation antibody targeting the same
protein (Figure 1a, right). For N sequential cycles, the presence
of each site-speciﬁc modiﬁcation can be identiﬁed (Figure 1b),
yielding N subsets of image data for the same localization-based
single-molecule specimen. These data represent the molecule’s
combinatorial PTM proﬁle, consisting of N site-speciﬁc
modiﬁcations (Figure 1c). For example, when the probing/
imaging procedure is carried out for 10 cycles, 10 modiﬁcations
can be studied within individual protein molecules. In the case
of phosphorylation, this corresponds to a theoretical distribu-
tion of 210 = 1024 binary phosphorylation codes.
However, the successful implementation of multicycle
probing technology depends heavily on overcoming several
key challenges: (i) IF probing must be completely stripped after
each imaging cycle to prevent signal carry-over to the next
reprobing cycle; (ii) target antigenicity and specimen integrity
of the immobilized protein must be retained throughout
multiple probing/imaging/erasing cycles; and (iii) the
detection rate of the speciﬁc antigen by the antibody, which
is generally heterogeneous, must be brought up to a reliable
level to avoid false negatives. These challenges potentially
severely restrict the application of eSiMBlot to visualizing the
Figure 1. Schematic model of erasable single-molecule blotting (eSiMBlot). (a) Post-translational modiﬁcations of the immobilized proteins are
visualized using total internal reﬂection ﬂuorescence (TIRF) microscopy, a site-speciﬁc anti-PTM antibody, and a ﬂuorophore-labeled secondary
antibody. After image acquisition, erasing is performed by removing the probing antibodies and restoring antigenicity for another probing cycle. (b)
N images are acquired by sequential repetition of probing for diﬀerent modiﬁcations over N cycles. (c) Following superimposition of N images,
combinatorial PTM codes of immobilized proteins are deciphered via localization-based proﬁling of ﬂuorescence signals.
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proﬁle of combinatorial PTM codes and must therefore be
carefully considered.
Rapid and Stable Covalent Immobilization Using Cu-
free Click Reaction. The key requirements for eSiMBlot are
the complete erasing of IF labeling and the stable
immobilization of proteins of interest in the single-molecule
surface, which must be maintained during the repeated probing
and erasing cycles. The antigen−antibody binding is well-
known as a high aﬃnity protein−protein interaction. Although
Shema et al. reported single-nucleosome modiﬁcation codes by
Figure 2. Stable and robust protein immobilization on the imaging surface by copper-free click chemistry. (a, b) An azide glass surface is prepared by
conjugation of azide-PEG-COOH to an amine-functionalized glass surface using conventional EDC coupling. Both DBCO- and dye-conjugated
proteins are immobilized on the click surface by a strain-promoted azide−alkyne cycloaddition reaction. Scale bar, 5 μm. (c) DBCO-conjugated
rabbit IgG proteins are immobilized on the click surface. After repetition of erasing (E) and reprobing (P) with Alexa Fluor 488-labeled antirabbit
IgG antibody, representative TIRF images of Alexa Fluor 488 signals that remained were detected by immobilized rabbit IgG proteins. Scale bar, 10
μm. (d) Average numbers of ﬂuorescent molecules per imaging area (Nf). Error bars denote standard deviation (n > 8). *P < 0.005, Student’s t-test.
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the repeated probing and washing cycles,12 the passive washing
is generally not enough to completely remove the IF antibodies
bounded on the antigens (see Supporting Information, Figure
S1). To strip the IF antibodies from the single-molecule
surface, we applied a low-pH/detergent-based erasing buﬀer
after SiMBlot assay of a model protein such as in vitro
autophosphorylated epidermal growth factor receptor (EGFR, a
transmembrane receptor protein for the epidermal growth
factors (EGFs) family of extracellular ligands)15 with anti-pTyr
primary antibody and an Alexa Fluor 555-labeled secondary
antibody. As shown in Figure S2 (see Supporting Information),
brief exposure to this buﬀer achieved quick and eﬃcient erasing
on the biotin-NeutrAvidin (Bt-NA) single-molecule surface.
This eﬃciency was possible for two reasons. First, IF probing
does not involve formation of large precipitates. Second, the
immobilized proteins are generally denatured to their unfolded
linear forms by exposure to low pH and ionic detergent,
allowing more eﬃcient immunolabeling; therefore, protein−
protein complexes, including antigen−antibody complexes, can
be easily disrupted by exposure to the erasing buﬀer. Thus, the
erasing condition is successfully optimized to completely strip
IF labeling.
Next, we tested whether the immobilized proteins could be
repeatedly detected by IF relabeling with the same antibodies.
The results revealed that signals from repeated IF gradually
decreased during multiple probing/erasing cycles (see Support-
ing Information Figure S3). As shown in Figures S4 and S5 (see
Supporting Information), this decrease arose from the loss of
immobilized proteins from the Bt-NA single-molecule surface,
rather than the surface-coating NA. Therefore, to stably retain
immobilized proteins through multiple rounds of erasing and
relabeling, it was necessary to develop a new single-molecule
surface.
In place of Bt-NA pairing, which has been widely used for
biomolecule immobilization on surfaces, we employed a form
of copper-free click chemistry, the strain-promoted azide−
alkyne cycloaddition (SPAAC) reaction,16 to covalently
immobilize a protein of interest in the single-molecule surface17
(Figure 2a). Because Bt-NA pairing is a ligand−protein
interaction, it is easily disrupted by exposure to the erasing
buﬀer, resulting in loss of protein function due to denaturation
(see Supporting Information Figures S3 and S5). However, the
triazole linkage, a stable covalent bond generated by the
SPAAC reaction, could provide highly selective and permanent
immobilization of a protein of interest in the single-molecule
surface. To determine whether the SPAAC reaction is suitable
for the eSiMBlot assay system (i.e., for both immobilization of a
speciﬁc protein on the single-molecule surface and resistance to
multiple erasing procedures), we developed a click single-
molecule surface (hereafter, termed the click surface) coated
with azide-terminal polyethylene glycol to provide a bio-
orthogonal reaction with dibenzocyclooctyl (DBCO)-tagged
proteins and prevent nonspeciﬁc adsorption of antibodies,
thereby minimizing false positives18 (Figure 2a). Next, we
prepared DBCO-conjugated ﬂuorescent IgG proteins and
applied them to the click surface. The results revealed that
Figure 3. Repetitive immunolabeling and imaging on a single antigen peptide molecule. (a) DBCO-labeled HA peptides were prepared by
conjugation of NHS-PEG4-DBCO to N-terminal amine of HA peptides using a conventional NHS reaction. (b) DBCO-labeled HA peptides and
ﬁducial marker proteins were immobilized on the click surface. Immobilized HA peptides were visualized using anti-HA tag antibody and Alexa Fluor
555-labeled secondary antibodies. Scale bar, 5 μm. (c) Average numbers of ﬂuorescent molecules per imaging area (Nf). (d) Average colocalization
ratio of ﬂuorescence signals in images of two diﬀerent cycles, which were corrected using ﬁducial markers. (e) Graph shows theoretical or
experimental detection coverages using anti-HA antibody and Alexa Fluor 555-labeled secondary antibody, depending on the number of cycles. Error
bars denote standard deviation (n > 8).
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the SPAAC reaction speciﬁcally immobilized DBCO-conju-
gated proteins on the click surface (see Supporting Information
Figure S6 and Figure 2b). In addition, we examined the stability
of covalent immobilization on the click surface over multiple
cycles of erasing. Fluorescence signals (Nf = 1311 ± 135) from
the immobilized proteins on the click surface were stably
retained even after 10 exposures to the erasing buﬀer (see
Supporting Information Figure S7). Furthermore, to determine
whether the immobilized proteins could be repeatedly detected
by probing antibody, we prepared and immobilized the DBCO-
conjugated rabbit IgG protein on the click surface and
performed the multicycle imaging procedure with ﬂuorescently
labeled antirabbit IgG secondary antibody (see Supporting
Information Figure S8 and Figure 2c). In contrast to the
gradual detachment of immobilized proteins on the Bt-NA
single-molecule surface (see Supporting Information Figure
S3), the immobilized proteins on the click surface (Nf = 330 ±
28) could be repeatedly and consistently probed with
ﬂuorescently labeled secondary antibody (Figure 2d), suggest-
ing that covalent immobilization on the click surface by SPAAC
reaction was immune to multiple erasing procedures. There-
fore, unlike Bt-NA pairing, SPAAC reaction on the click surface
enables stable immobilization of target proteins, and the click
surface is well suited for implementation of eSiMBlot.
Repetitive Reprobing on a Single Antigen Peptide.
Complete removal of IF labeling and antigen regeneration of
the immobilized proteins is essential for the success of the
eSiMBlot assay system. To carefully validate reprobing ability,
we used HA peptide N-terminally conjugated to a DBCO
functional group as the single antigen molecule19 (Figure 3a),
and DBCO- and Alexa Fluor 488-labeled goat IgG protein as
the ﬁducial marker on the click surface (see Supporting
Information Figures S6 and S9). After immobilization of the
HA peptide and the ﬁducial marker, we performed eSiMBlot
analysis with anti-HA primary antibody and Alexa Fluor 555-
labeled secondary antibody (Figure 3b). In each cycle, the
number of Alexa Fluor 555 signals remained constant (Nf = 422
± 32, Figure 3c). Furthermore, to conﬁrm whether unremoved
primary or secondary antibody might persist between probing/
erasing rounds, we performed IF labeling with only
ﬂuorescently labeled secondary antibody in the ﬁnal round,
and then counted the number of ﬂuorescence molecules. As
shown in Figure 3c, a small number of ﬂuorescence signals was
detected even after seven rounds of IF labeling of HA peptides.
These observations suggested that the eSiMBlot assay
eliminated the potential risk of continued occupancy by
persistent antibodies or steric hindrance from multicolor IF
labeling.
Next, we superimposed the multicycle ﬂuorescence image
data sets for immobilized HA peptides detected by IF labeling,
using the data sets for the ﬁducial marker as a guide. We applied
colocalization analysis to two images of multicycle data sets on
the same imaging plane. The pairwise colocalization ratio of
each image (Rd = P(x|y), where x, y cycles are diﬀerent) was
Figure 4. eSiMBlot enables decoding of multiple modiﬁcations at single-molecule resolution. (a) Illustration of experimental procedures. After
starvation for 24 h, 293T cells expressing SNAP-EGFR-eGFP-ﬂag (rEGFR) were extracted using lysis buﬀer containing 10 μM AG1478. For in vitro
SNAP-tag labeling and autophosphorylation, aﬃnity-puriﬁed rEGFR was labeled with 2 μM benzylguanine-derived reagent (BG-PEG13-DBCO),
followed by incubation with 100 ng mL−1 EGF and 100 μM ATP for 1 h. Autophosphorylation sites of rEGFR immobilized on the click surface were
quantiﬁed by the eSiMBlot assay with the indicated antibodies (pY845, pY992, pY998, pY1068, pY1086, and pY1173). (b) Representative eSiMBlot
images of Alexa Fluor 555 signals generated by probing site-speciﬁc phosphorylation with the indicated primary and ﬂuorescently labeled secondary
antibodies in each cycle. Scale bar, 5 μm. (c) Average numbers of ﬂuorescent molecules per imaging area (Nf). (d) Graph shows average numbers of
the 63 (26 − 1) combinatorial PTM codes per imaging area (Nf). A computer-generated binary code is placed below the corresponding bar. (e) The
phospho-stoichiometry distribution of each categorized combinatorial phospho-code. Error bars denote standard deviation (n > 8).
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27%, suggesting a detection rate of anti-HA antibody (Figure
3d). A low antigen detection rate by an antibody such as anti-
HA could severely decrease conﬁdence about the results of the
eSiMBlot assay. To address this issue, we designed an
experimental strategy of cumulative detection from multiple
image data sets, with repetitive reversible labeling of the same
antigens. This approach could achieve a higher antigen
detection rate, as estimated by theoretical simulation for the
cumulative detection rate (Tn = 1 − (1 − Rd)n, where n is the
cumulative cycle number; Figure 3e). Surprisingly, we found
that the experimental detection with anti-HA antibody
following six rounds of probing/erasing reached 75%, with a
correlation coeﬃcient (r = 0.999) between experimental and
theoretical coverages very close to 1, promising that cumulative
detection from multicycle images could compensate for low or
heterogeneous antigen detection rates among antibodies.
Collectively, these results veriﬁed complete removal of
antigen-speciﬁc IF labeling by the erasing buﬀer and showed
that cumulative detection of a single antigen sequence could
increase the antibody detection rate, decreasing the likelihood
of false negatives.
Decoding of Multisite Phospho-EGFR. After addressing
the key challenges of the eSiMBlot assay, we tested the power
of this approach to directly visualize multisite PTM codes in
individual protein molecules. For these proof-of-principle
experiments, we used in vitro autophosphorylated recombinant
EGFR (rEGFR) tagged with enhanced green ﬂuorescence
protein (eGFP), SNAP-tag,20 and FLAG antigen sequences,21
isolated by aﬃnity puriﬁcation with anti-FLAG beads (Figure
4a). EGFR is a distinct subfamily of receptor tyrosine kinases.
When extracellular ligands such as EGFs bind to EGFR,
autophosphorylations occur on multiple tyrosine residues in the
cytoplasmic domain of EGFR to induce signal pathways in
cells.15 We anticipated that most tyrosine residues of the
puriﬁed rEGFR proteins would be fully phosphorylated in in
vitro conditions, as conﬁrmed by immunoblotting (see
Supporting Information Figure S10). To immobilize rEGFR,
a protein of interest, on the click surface, site-speciﬁc labeling of
the fusion proteins with a DBCO functional group was
necessary. Hence, we synthesized a benzylguanine (BG)
derivative, BG-PEG13-DBCO, as a substrate of the SNAP-tag,
leading to irreversible covalent labeling of the SNAP-tag with
DBCO (see Supporting Information Figure S11, Methods).20
After immobilization of rEGFR on the click surface (see
Supporting Information Figure S12), we performed the
eSiMBlot assay with six diﬀerent site-speciﬁc phospho-antibod-
ies (pTyr845, pTyr992, pTyr998, pTyr1068, pTyr1082, and
pTyr1173 of EGFR, Figure 4b) to individually examine each
autophosphorylation site of rEGFR. In an analysis of more than
2500 autophosphorylated rEGFR molecules (Nf = 527 ± 22),
we quantiﬁed each potential combinatorial phosphorylation
(total: 26 − 1 = 63 binary codes) in individual rEGFR proteins
Figure 5. Proﬁling of ligand-induced EGFR phospho-codes by eSiMBlot assay. (a) Illustration of experimental procedures. After starvation for 24 h,
COS7 cells ectopically expressing SNAP-EGFR-eGFP-Flag (rEGFR) were incubated with or without 100 ng mL−1 EGF and/or 1 mM pervanadate
for 10 min. Proteins were extracted using lysis buﬀer containing 10 μM AG1478. rEGFR was isolated from cell lysates by aﬃnity puriﬁcation and in
vitro labeled with 2 μM BG-PEG13-DBCO. The eluates were applied to the click surface. (b) Tyrosine phosphorylations of immobilized rEGFR
proteins were probed by a primary antibody against tyrosine phosphorylation and an Alexa Fluor 555-labeled secondary antibody. Graphs show the
ratio of pY on rEGFR and fold changes. (c) Immobilized rEGFR proteins were analyzed by the eSiMBlot assay with the indicated primary antibodies
(pT669, pY845, pY992, pY998, pY1068, pY1086, and pY1173) and an Alexa555-labeled secondary antibody. Graph shows fold changes of ratios of
each site-speciﬁc phosphorylation on rEGFR. (d) Phospho-stoichiometry distribution of each categorized combinatorial phospho-code. (e) Fold
changes of multiphosphorylation ratios of each site-speciﬁc phosphorylation on rEGFR. Error bars denote standard deviation (n > 4). *P < 0.05,
Student’s t-test.
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(Figure 4c). As expected, the distribution of observed
molecules over the possible binary phospho-codes (Figure
4d) revealed that the most abundant combinatorial code was
fully autophosphorylated rEGFR (18%), whereas the average
number of each of the other binary codes was signiﬁcantly
lower (1%). Moreover, the phospho-stoichiometry distribution
demonstrated that the in vitro autophosphorylations dramati-
cally reduced the level of the monophosphorylated forms from
95.1% to 22.5%, but increased the level of the multi-
phosphorylated forms from 4.9% to 77.5% (Figure 4e).
Together, these results demonstrate that the eSiMBlot assay
enabled direct and quantitative analysis of multisite PTM codes
of individual protein molecules, information that had previously
been hidden in ensemble results.
Ligand-Induced EGFR Phospho-Codes. Next, we exam-
ined the ability of the eSiMBlot assay to measure changes in
combinatorial PTM codes in response to environmental
stimuli. As noted above, we conﬁrmed that the accumulation
of tyrosine phosphorylation due to in vitro EGFR autophos-
phorylations, which are immune to dephosphorylation by
phosphatases, would generate a fully phosphorylated form of
EGFR (Figure 4). Moreover, Kleiman et al.22 reported that, in
response to ligand, EGFR phosphorylations in cells have very
short half-lives due to the potent activities of endogenous
phosphatases. To determine whether monophosphorylated
EGFRs on cells are derived from phosphatases that prevent
the accumulation of EGFR phosphorylation, we used the
eSiMBlot assay to thoroughly analyze the combinatorial
phospho-codes of EGFR in response to treatment of living
cells with EGF and/or pervanadate.23 In these experiments,
COS7 cells ectopically expressing rEGFR were serum-starved
for 12 h. After treating the cells with EGF (100 ng mL−1) and/
or pervanadate (1 mM) for 10 min, we isolated rEGFR from
crude cell extracts by aﬃnity puriﬁcation and labeled the SNAP-
tag with BG derivatives (BG-PEG13-DBCO), as shown in
Figure 5a. Next, the eluates were immobilized onto the single-
molecule surface by the SPAAC reaction and probed with anti-
pTyr primary antibody and Alexa Fluor 555-labeled secondary
antibody (Figure 5b). In addition, we performed the eSiMBlot
analysis with multiple site-speciﬁc phospho-antibody sets
(pThr669, pTyr845, pTyr992, pTyr998, pTyr1068, pTyr1082,
and pTyr1173 of EGFR, Figure 5c). Levels of overall tyrosine
phosphorylation and each site-speciﬁc phosphorylation sig-
niﬁcantly increased in response to treatment with EGF and/or
pervanadate.
Furthermore, we successfully coregistered all seven image
data sets with site-speciﬁc IF labeling, using the data sets for the
ﬁducial marker as a guide. From the analysis of over 10 000
rEGFR molecules, we could quantify the molecular ratio of 27
− 1 = 127 binary codes, corresponding to the possible
combinatorial phosphorylations, in individual phosphorylated
rEGFR proteins (see Supporting Information Figure S13).
Ligand-induced multiple phosphorylations of receptor tyrosine
kinases are widely believed to occur, based on the results of
ensemble biochemical assays;24−26 however, our recently
published results call into question the prevalent model that
EGF induces multiple phosphorylations of EGFR on the cell
membrane.11 Remarkably, we observed that the combinatorial
PTM distribution of rEGFR molecules was strongly biased
toward monophosphorylation codes (NT: 94.4%, EGF: 94.5%,
Figure 5d). These results strongly support the idea that EGF-
induced EGFR on the cell membrane is rarely multi-
phosphorylated.
Furthermore, the ratios of multiphosphorylated EGFR forms,
which were unchanged by EGF treatment alone, signiﬁcantly
increased from 5.6% to 8.3% or 13.9% of total phosphorylated
EGFR molecules upon treatment with pervanadate in the
absence or presence of EGF, respectively (Figure 5d).
Moreover, all multiphosphorylation ratios of each site-speciﬁc
phosphorylation of EGFR increased upon treatments with
pervanadate, with or without EGF (see Supporting Information
Figure S14 and Figure 5e). In particular, cotreatment with EGF
and pervanadate signiﬁcantly increased the multiphosphoryla-
tion ratio of pY1173 of EGFR, which recruits SHP1
phosphatase for EGFR dephosphorylation,27 2-fold relative to
pervanadate treatment alone. However, most ratios were
slightly decreased by EGF treatment alone (Figure 5e), even
though the level of each site-speciﬁc phosphorylation was
elevated (Figure 5c). These outcomes may be due to inhibition
of endogenous phosphatase activities, which enables the
accumulation of phosphorylation on individual EGFR mole-
cules by preventing dephosphorylation, as in the in vitro
environment (Figure 4). Accordingly, in contrast to conven-
tional methods, the detailed analysis of combinatorial phospho-
codes of EGFR by eSiMBlot assay suggested that the balance
between kinase and phosphatase activities is intimately involved
in the control of ligand-dependent combinatorial phosphor-
ylation patterns of EGFR in living cells (see Supporting
Information Figure S15). Although we examined only ligand-
induced EGFR phospho-codes in our investigation of
physiological combinatorial PTMs (Figure 5), we followed
routine and well-established biochemical procedures for the
sample preparation, e.g., aﬃnity puriﬁcation and in vitro SNAP-
tag labeling. Therefore, we are conﬁdent that the eSiMBlot
assay is well suited to the study of combinatorial PTM codes in
general, allowing unprecedented straightforward visualization of
combinatorial site-speciﬁc PTMs within individual signaling
molecules.
■ DISCUSSION
We have established a platform technology for proteomic
approaches, based on multiplexed single-molecule imaging
techniques, for analysis of the combinatorial PTM codes of
diverse cellular proteins. The platform relies on the
combination of Cu-free click chemistry, cyclic probing with
diﬀerent antibodies and single molecule ﬂuorescence imaging.
In some sense, the eSiMBlot technique can be viewed as an
extension of serial stripping and reprobing in western blots, but
the technical evolution from ensemble to single molecules
confers several incomparable advantages, and also enjoys the
merits of previous single-molecule isolation techniques such as
a rapid, sensitive experimental procedure and the ability to use
small amounts of specimen.11,28 First, eSiMBlot can easily and
rapidly provide exquisite quantitative data regarding the status
of multiple PTMs at a single-molecule level, without any
limitations on the number of colors or antibody host species.
Second, the erasing process completely eliminates concerns
about steric hindrance (also known as epitope occlusion) due
to multicolor IF labeling on a single polypeptide, as well as
overcoming issues related to the heterogeneous sensitivity of
primary antibodies by allowing superimposition of images from
repeated rounds of probing. Third, if proper site-speciﬁc
modiﬁcation antibodies for a protein of interest are available,
the method can provide an unprecedented level of information
about combinatorial PTM codes that had previously been
concealed in ensemble results. This detailed information on
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diﬀerent PTM code states in subpopulations sheds new light on
the events and the regulation of intracellular signaling11,12 and
may help molecular diagnostics by identifying clinical
biomarkers for precision medicine.29,30 Moreover, in combina-
tion with microﬂuidics platforms for single-cell study,31
eSiMBlot could be extended to measurement of cell-to-cell
variations in combinatorial PTM codes. Alternatively, in
conjunction with automated imaging systems,32 the technique
could liberate researchers from the need to perform labor-
intensive manual experiments.
PTM codes can modulate protein activity, directional and
dynamic protein−protein interactions, or allosteric eﬀects as if
they were digital logic gates,33 and these phenomena can in
turn aﬀect PTM codes.34 In particular, PTM codes are closely
linked with interactome proﬁles;24,35 however, it remains
diﬃcult to determine how PTM codes are related with multiple
protein−protein interactions. In addition, the inﬂuence of PTM
codes on protein functions, including enzyme activity and
conformational changes, has barely been elucidated. Because
eSiMBlot can double as a preparatory tool for analyzing
individual complex proteins at the single-molecule level,28 it
could help elucidate these relationships by sequential analysis of
protein complexes and PTM codes on the same molecule,
which is currently impossible using conventional methods.
■ METHODS
No unexpected or unusually high safety hazards were
encountered.
Antibodies and Reagents. Antibodies against EGFR and
phospho-EGFR (pThr669, pTyr998, pTyr1068, and
pTyr1173) were purchased from Cell Signaling Technology
(Cat. #2239, #3056, #2641, #2236, and #4407). Monoclonal
anti-pTyr845 EGFR antibody and centrifugal ﬁlter unit were
purchased from Millipore (Cat. #04-283, #UFC503024).
Polyclonal anti-pTyr992 EGFR antibody was purchased from
Abcam (Cat. #ab5638). Polyclonal anti-pTyr1086 EGFR
antibody, ﬂuorescently labeled secondary antibodies and
Lipofectamine were purchased from Invitrogen Life Technol-
ogy (Cat. #44790G, #A21110, #A11001, #A11034, #A21424,
#A21429, and #18324). Recombinant human EGF was
purchased from R&D Systems (Cat. #236-EG). Sulfo-NHS-
DBCO and NHS-PEG13-DBCO were purchased from Click
Chemistry Tools (Cat. #A124 and #1015). Anti-FLAG M2
aﬃnity gel, 3X FLAG peptide, HA peptide, and Phosphatase
Inhibitor Cocktails 2&3 were purchased from Sigma-Aldrich
(Cat. #A2220, #F4799, #I2149, #5726, and #P0044).
Cell Culture and Transfection. COS7 cells were
maintained in Dulbecco’s Modiﬁed Eagle’s medium (DMEM)
supplemented with 10% (v/v) fetal bovine serum at 37 °C in a
humidiﬁed CO2-controlled (5%) incubator. For transfection
and transient expression of recombinant proteins, cells were
transfected with plasmids encoding rEGFR using Lipofect-
amine and then cultured for an additional 48 h to achieve
ectopic expression of rEGFR.
Plasmids. A plasmid encoding C-terminal Flag-tagged
eGFP was constructed by insertion of the corresponding
cDNA sequences of eGFP into the XbaI/AgeI sites of the
pcDNA 3.1 myc/his vector (Invitrogen). The inserted DNA
fragment encoding C-terminally FLAG-tagged eGFP was
prepared by PCR using vector pEGFP-C1 (Clontech
Laboratory Inc.) as the template and the following primers:
forward (XbaI): 5′-GCTCTAGAGGAGGG ATGGTGA-
GCAAGGGCGAGGAG-3′; reverse (AgeI): 5′-C AC-
CGGTTCA CTTGTCGTCATCGTCTTTGTAGTC
CTTGTACAGCTCGTC-3′. The WT construct was cloned
by inserting the N-terminus of the cDNA sequence of full-
length EGFR lacking a stop codon into the NotI/XbaI sites of
pcDNA3.1 eGFP-FLAG. To insert two restriction sites (AscI
and SacII) between the signal peptide (SP) and membrane
protein sequence (MP) of EGFR, two DNA fragments
encoding the N-terminal SP or C-terminal MP sequences
with two restriction sites were prepared by PCR using
pcDNA3.1 EGFR WT-eGFP-FLAG as the template and the
following primer sets: N-terminal SP sequence, forward: 5′-
CGCAAATGGGCGGTAGGCGTG-3′ and reverse (SacII/
AscI): 5′-CCGCGGTTGGCGCGCC AGCCCGACT-
CGCCGGGCAGAG-3′; C-terminal MP sequence, forward
(AscI/SacII): 5′-GGCGCGCCAACCGCGG CTGGAGGA-
AAAGAAAGTTTGC-3′ and reverse (XbaI): 5′-GC TCTAGA
TGCTCCAATAAATTCACTGCT-3′. The DNA fragment
encoding EGFR WT (AscI/SacII) was prepared by overlapping
PCR using the two DNA fragments as the template and the
following primers: forward: 5′-CGCAAATGGGCGGTA-
GGCGTG-3′; reverse: 5′-GC TCTAGA TGCTCCAA-
TAAATTCACTGCT-3′. The construct for EGFR WT-eGFP-
FLAG (AscI/SacII) was cloned by inserting the integrated DNA
fragment into pcDNA3.1 eGFP-FLAG at the NotI/XbaI sites.
In addition, a plasmid encoding N-terminal SNAP-tagged
EGFR WT-eGFP-Flag was constructed by insertion of the
cDNA sequences encoding the SNAP-tag into the AscI/SacII
sites of the modiﬁed EGFR WT-eGFP-FLAG construct. The
SNAP-tag DNA fragment was prepared by PCR using vector
pSNAPf (NEB) as the template and the following primers:
f o rwa r d (As c I ) : 5 ′ -GGCGCGCCACATCATCA-
CCATCACCAT ATGGACAAAGACTGCGAAATG-3′; re-
verse (SacII): 5′-TCC CCGCGG CCCTCCACTCCCACT
ACCCAGCCCAGGCTTGCCCAG-3′.
Synthesis of BG-PEG13-DBCO. O
6-[4-(Aminomethyl)-
benzyl]guanine (Matrix Scientiﬁc, 2.7 mg, 0.01 mmol) was
suspended in dry DMF (0.7 mL) under an argon atmosphere,
and trimethylamine (10 μL) and DBCO-PEG13-NHS (Click
Chemistry Tools, 10 mg, 0.01 mmol) in dry DMF (0.3 mL)
were added. After being stirred for 24 h at room temperature,
the crude product was puriﬁed by HPLC. The puriﬁed
compound was dried under reduced pressure to yield BG-
PEG13-DBCO (5.5 mg, 47%). MS(ESI): m/z calculated for [M
+ H+]: 1201.6; observed, 1201.6.
Synthesis of DBCO-Conjugated HA Peptide. Inﬂuenza
hemagglutinin (HA) peptide (Sigma-Aldrich, 0.1 mg, 0.09
μmol) was suspended in dry DMF (0.2 mL) under an argon
atmosphere, and trimethylamine (2 μL) and DBCO-PEG4-
NHS (Click Chemistry Tools, 1 mg, 1.54 μmol) in dry DMF
(0.1 mL) were added. After being stirred for 24 h at room
temperature, the crude product was puriﬁed by HPLC. The
puriﬁed compound was dried under reduced pressure to yield
DBCO-PEG4-HA peptide (65 μg, 44%). MS(ESI): m/z
calculated for [M + H+]: 1636.7; observed, 1636.3.
Preparation of Both DBCO- and Dye-Conjugated
Proteins. Alexa Fluor 488-labeled antihamster goat IgG
(Invitrogen, 0.2 mg) or bovine serum albumin (Invitrogen,
#A13100, 0.2 mg) was suspended in 0.3 mL of PBS. DBCO-
PEG4-NHS (Click Chemistry Tools, 0.1 mg) was suspended in
PBS (0.2 mL). After 1 h of stirring at room temperature, the
crude product was puriﬁed by diaﬁltration using a centrifugal
ﬁlter (Millipore, 30 kDa MWCO). Samples were subjected to
single-molecule imaging or immunoblotting.
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Preparation of in Vitro Autophosphorylated EGFR.
COS7 cells ectopically expressing rEGFR were serum-starved
for 12 h. After labeling of cell surface proteins with Sulfo-NHS-
DBCO and preparation cell lysate using lysis buﬀer containing
AG1478 (10 μM), rEGFR was aﬃnity-puriﬁed using anti-
FLAG M2-conjugated agarose, followed by three washes with
lysis buﬀer (AG1478-free) and two washes with kinase buﬀer
(25 mM HEPES, pH 7.4, 20 mM MgCl2, 5 mM β-
glycerophosphate, 0.5 mM dithiothreitol, and 0.1 mM sodium
orthovanadate). Immunoprecipitates were eluted from beads
with 0.1 mg mL−1 3× FLAG peptide at 4 °C for 30 min.
Puriﬁed rEGFR was incubated for 1 h at 30 °C with shaking.
EGFR was activated by addition of ATP (0.1 mM) and EGF
(100 ng mL−1) prepared in kinase buﬀer. Samples were
subjected to single-molecule imaging or immunoblotting.
Preparation of EGFR Proteins from Cells. COS7 cells
ectopically expressing rEGFR were serum-starved for 12 h.
Cells were treated with a ligand such as EGF at 37 °C for 10
min and washed with ice-cold PBS. Cells were lysed in lysis
buﬀer (50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1
mM EDTA, 5% glycerol, 1% NP-40, 10 μM AG1478, and
phosphatase inhibitor cocktails) by sonication, and cell lysates
were centrifuged at 13 500 rpm at 4 °C for 10 min. From
supernatants, rEGFR was aﬃnity-puriﬁed using anti-FLAG M2-
conjugated agarose, followed by three washes with lysis buﬀer
(AG1478-free) and one wash with PBS. Immunoprecipitates
were labeled with BG derivatives (BG-PEG13-DBCO) for 30
min at 30 °C, and then washed four times with ice-cold PBS.
The immunoprecipitates were eluted from beads with 0.1 mg
mL−1 3× FLAG peptide for 30 min at room temperature.
Eluates were subjected to single-molecule imaging or
immunoblotting.
Flow Chambers and Single-Molecule Immobilization.
Extensively cleaned cover glasses were prepared by washing
with H2O and 1 M KOH for 2 h or longer, and then were
treated with 3-(2-aminoethylamino)-propyltrimethoxysilane
(Tokyo Chemical Industry Co., Cat. #A0774) and doped
with azide-PEG (Laysan Bio, Inc., azide-PEG-COOH-5000) or
a mixture of mPEG and biotin-PEG (Laysan Bio, Inc., mPEG-
SVA-5000 and Biotin-PEG-SVA-5000) at a mass ratio of 25:1
(mPEG:biotin-PEG). In the case of the biotin surface, the ﬂow
chambers were coated with NeutrAvidin (Thermo Scientiﬁc,
Cat. #31000).28
Before immobilization on the single-molecule surface,
samples were serially diluted to obtain well-isolated spots on
the single-molecule surface after incubation for 10 min. All
dilutions were made immediately before experiments with PBS
(0.1 mg mL−1 bovine serum albumin). Unbound antibodies
and samples were removed from the channels by washing twice
with buﬀer SB18 (40 mM HEPES, 105 mM NaCl, 5 mM KCl,
5 mM MgCl2, 0.05% [vol/vol] Tween-20, and 0.1 mg mL
−1
bovine serum albumin, pH 8.0). The channels were blocked
with SB18 (1.0 mg mL−1 bovine serum albumin was added).
For IF detection, immobilized protein molecules were
incubated with a primary antibody (13.3 nM) against the
prey protein for 10 min, and with a ﬂuorescent dye-labeled
secondary antibody (2.66 nM) for 10 min immediately before
imaging. After image acquisition, the previous antibodies were
removed from the channels by washing twice with erasing
buﬀer (IgG elution buﬀer added with 2% SDS and adjusted pH
1.85) and incubating for 5 min. For multiple rounds of
relabeling, the ﬂow channels were neutralized by washing three
times with PBS, and then blocked with SB18 containing bovine
serum albumin (1.0 mg mL−1).
Single-Molecule Imaging Analysis. An objective-type
TIRF microscope (Nikon Ti-E, Hamamatsu EM-CCD) was
used to acquire single-molecule data.28 eGFP and Alexa Fluor
488 were excited at 488 nm, and Alexa Fluor 555 was excited at
532 nm. Narrow band-pass ﬁlters (Chroma) were used to avoid
crosstalk between channels. All experiments were performed at
room temperature unless otherwise speciﬁed. Single-molecule
analysis was performed as previously described.11 The mean
spot count per image (imaging area, 3000 μm2) and standard
deviation were calculated from images of ﬁve or more diﬀerent
regions.
Colocalization between diﬀerent rounds of relabeling was
assessed as described previously, with minor modiﬁcations.28
Brieﬂy, two separate movies of the same region were taken
using Alexa Fluor 488 as a ﬁducial marker and Alexa Fluor 555
to detect site-speciﬁc modiﬁcation on a single polypeptide
molecule. The ﬂuorescent spots in both images were ﬁtted with
Gaussian proﬁles to determine the center positions of the
molecules to half-pixel accuracy. Next, the positions of the
ﬂuorescent spots between diﬀerent rounds of relabeling, which
drifted on the X−Y stage, were corrected using the positions of
the ﬁducial markers. The ﬂuorescent spots between diﬀerent
rounds of relabeling, whose center was within a distance of
three pixels (∼300 nm), were determined as colocalization
spots. The ratio of combinatorial PTM codes was calculated as
the number of colocalized molecules divided by the total
number of ﬂuorescent signals.
Statistical Analysis. All data are presented as means ±
standard deviation, or as images representative of at least three
sets of independent experiments. When necessary, data were
statistically analyzed using Student’s t-test.
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